Published in Proc Natl Acad Sci U S A on October 29, 2003
Repair of topoisomerase I-mediated DNA damage. Prog Nucleic Acid Res Mol Biol (2006) 2.16
Human DNA topoisomerase I: relaxation, roles, and damage control. Chromosoma (2005) 1.51
A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex. Mol Cancer Ther (2006) 1.36
Cellular strategies for regulating DNA supercoiling: a single-molecule perspective. Cell (2010) 1.25
Analysis of human immunodeficiency virus type 1 Gag dimerization-induced assembly. J Virol (2005) 1.08
Tryptophane-205 of human topoisomerase I is essential for camptothecin inhibition of negative but not positive supercoil removal. Nucleic Acids Res (2007) 0.95
Mutation of Gly721 alters DNA topoisomerase I active site architecture and sensitivity to camptothecin. J Biol Chem (2007) 0.94
Role of the linker domain and the 203-214 N-terminal residues in the human topoisomerase I DNA complex dynamics. Biophys J (2004) 0.94
Effect on DNA relaxation of the single Thr718Ala mutation in human topoisomerase I: a functional and molecular dynamics study. Nucleic Acids Res (2005) 0.94
Rotation of DNA around intact strand in human topoisomerase I implies distinct mechanisms for positive and negative supercoil relaxation. Nucleic Acids Res (2005) 0.93
Free energy calculations reveal rotating-ratchet mechanism for DNA supercoil relaxation by topoisomerase IB and its inhibition. Biophys J (2010) 0.90
The open state of human topoisomerase I as probed by molecular dynamics simulation. Nucleic Acids Res (2007) 0.87
Pyridoxal 5'-phosphate inactivates DNA topoisomerase IB by modifying the lysine general acid. Nucleic Acids Res (2004) 0.79
Disulfide cross-links reveal conserved features of DNA topoisomerase I architecture and a role for the N terminus in clamp closure. J Biol Chem (2008) 0.79
DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin. J Biol Chem (2015) 0.77
Autonomously folded α-helical lockers promote RNAi. Sci Rep (2016) 0.75
DNA topoisomerases: structure, function, and mechanism. Annu Rev Biochem (2001) 12.53
Cellular roles of DNA topoisomerases: a molecular perspective. Nat Rev Mol Cell Biol (2002) 11.79
Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science (1998) 4.51
A model for the mechanism of human topoisomerase I. Science (1998) 4.10
The mechanism of topoisomerase I poisoning by a camptothecin analog. Proc Natl Acad Sci U S A (2002) 3.71
Tumor cell death induced by topoisomerase-targeting drugs. Annu Rev Pharmacol Toxicol (2001) 2.97
Supercoiling of intracellular DNA can occur in eukaryotic cells. Cell (1988) 2.69
Conservation of structure and mechanism between eukaryotic topoisomerase I and site-specific recombinases. Cell (1998) 2.40
Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme. Biochim Biophys Acta (1998) 2.35
Mechanism of action of camptothecin. Ann N Y Acad Sci (2000) 2.01
DNA transport by a type II topoisomerase: direct evidence for a two-gate mechanism. Proc Natl Acad Sci U S A (1996) 1.77
Alterations in the catalytic activity of yeast DNA topoisomerase I result in cell cycle arrest and cell death. J Biol Chem (1997) 1.40
Non-reciprocal regulation of the redox state of the glutathione-glutaredoxin and thioredoxin systems. EMBO Rep (2003) 1.34
Structural flexibility in human topoisomerase I revealed in multiple non-isomorphous crystal structures. J Mol Biol (1999) 1.24
SCT1 mutants suppress the camptothecin sensitivity of yeast cells expressing wild-type DNA topoisomerase I. Proc Natl Acad Sci U S A (1995) 1.21
Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine. Cancer Res (1993) 1.18
Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity. Mol Pharmacol (1999) 1.17
Reconstitution of enzymatic activity by the association of the cap and catalytic domains of human topoisomerase I. J Biol Chem (2002) 1.12
Identification of a mutant human topoisomerase I with intact catalytic activity and resistance to 9-nitro-camptothecin. J Biol Chem (1994) 1.05
Substitutions of Asn-726 in the active site of yeast DNA topoisomerase I define novel mechanisms of stabilizing the covalent enzyme-DNA intermediate. J Biol Chem (2000) 1.00
Cancer therapeutics in yeast. Cancer Cell (2002) 0.99
DNA relaxation by human topoisomerase I occurs in the closed clamp conformation of the protein. Proc Natl Acad Sci U S A (2003) 0.98
Clinical use of topoisomerase I inhibitors in anticancer treatment. Med Pediatr Oncol (2000) 0.96
Molecular and biological determinants of the cytotoxic actions of camptothecins. Perspective for the development of new topoisomerase I inhibitors. Ann N Y Acad Sci (2000) 0.92
Active site mutations in DNA topoisomerase I distinguish the cytotoxic activities of camptothecin and the indolocarbazole, rebeccamycin. J Biol Chem (2001) 0.92
Intragenic suppressors of mutant DNA topoisomerase I-induced lethality diminish enzyme binding of DNA. J Biol Chem (1998) 0.90
Increased camptothecin toxicity induced in mammalian cells expressing Saccharomyces cerevisiae DNA topoisomerase I. J Biol Chem (1998) 0.89
Intradimerically tethered DNA topoisomerase II is catalytically active in DNA transport. Proc Natl Acad Sci U S A (1996) 0.87
Enzymes that push DNA around. Nat Struct Biol (1999) 0.85
Global analysis of protein phosphorylation in yeast. Nature (2005) 7.46
PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex. J Biol Chem (2007) 4.79
EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell (2009) 3.40
Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II. Mol Cell Biol (2009) 3.26
Antitumour drugs impede DNA uncoiling by topoisomerase I. Nature (2007) 2.77
Rapamycins: mechanism of action and cellular resistance. Cancer Biol Ther (2003) 2.31
Analyzing antibody specificity with whole proteome microarrays. Nat Biotechnol (2003) 1.98
Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis (2009) 1.89
EPHA2 is associated with age-related cortical cataract in mice and humans. PLoS Genet (2009) 1.82
Comparative gene genealogies indicate that two clonal lineages of Cryptococcus gattii in British Columbia resemble strains from other geographical areas. Eukaryot Cell (2005) 1.80
Endoscopic resection of small gastrointestinal stromal tumors. Dig Dis Sci (2010) 1.69
Increased expression of dystroglycan inhibits the growth and tumorigenicity of human mammary epithelial cells. Cancer Biol Ther (2004) 1.53
Alternative mechanisms by which mediator subunit MED1/TRAP220 regulates peroxisome proliferator-activated receptor gamma-stimulated adipogenesis and target gene expression. Mol Cell Biol (2007) 1.50
Bias-free true random-number generator. Opt Lett (2009) 1.49
Association between polymorphism in the promoter region of Interleukin 6 (-174 G/C) and risk of Alzheimer's disease: a meta-analysis. J Neurol (2011) 1.44
Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J Neurosci (2005) 1.43
Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex. EMBO Rep (2009) 1.42
Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J Immunol (2010) 1.42
Pachyonychia congenita with corneal dystrophy. J Dermatol (2013) 1.39
A novel active DNA topoisomerase I in Leishmania donovani. J Biol Chem (2002) 1.35
Up-regulated microRNA-146a negatively modulate Helicobacter pylori-induced inflammatory response in human gastric epithelial cells. Microbes Infect (2010) 1.33
Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: importance for excitatory amino acid transporter localization and function. J Biol Chem (2004) 1.32
Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer (2004) 1.32
TOR signaling is a determinant of cell survival in response to DNA damage. Mol Cell Biol (2007) 1.28
Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections. Clin Infect Dis (2008) 1.28
Cellular strategies for regulating DNA supercoiling: a single-molecule perspective. Cell (2010) 1.25
Association between polymorphisms in the promoter regions of matrix metalloproteinases (MMPs) and risk of cancer metastasis: a meta-analysis. PLoS One (2012) 1.24
Mechanism of histone methylation catalyzed by protein lysine methyltransferase SET7/9 and origin of product specificity. Proc Natl Acad Sci U S A (2007) 1.24
Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am J Pathol (2003) 1.23
The effect of new cooperative medical scheme on health outcomes and alleviating catastrophic health expenditure in China: a systematic review. PLoS One (2012) 1.20
The Cbln family of proteins interact with multiple signaling pathways. J Neurochem (2012) 1.18
Single mutation in the linker domain confers protein flexibility and camptothecin resistance to human topoisomerase I. J Biol Chem (2003) 1.18
A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo. PLoS One (2012) 1.15
Translational control of glial glutamate transporter EAAT2 expression. J Biol Chem (2006) 1.14
Tuning the surface charge properties of epitaxial InN nanowires. Nano Lett (2012) 1.09
Structure of a SUMO-binding-motif mimic bound to Smt3p-Ubc9p: conservation of a non-covalent ubiquitin-like protein-E2 complex as a platform for selective interactions within a SUMO pathway. J Mol Biol (2007) 1.08
Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom Inventory. J Pain Symptom Manage (2005) 1.07
Divergence, hybridization, and recombination in the mitochondrial genome of the human pathogenic yeast Cryptococcus gattii. Mol Ecol (2009) 1.06
Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21,789 patients. Eur J Gastroenterol Hepatol (2013) 1.05
Alpha-fetoprotein-thymidine kinase-luciferase knockin mice: a novel model for dual modality longitudinal imaging of tumorigenesis in liver. J Hepatol (2010) 1.04
Expression of members of the 28-kilodalton major outer membrane protein family of Ehrlichia chaffeensis during persistent infection. Infect Immun (2004) 1.02
Holoenzyme assembly and ATP-mediated conformational dynamics of topoisomerase VI. Nat Struct Mol Biol (2007) 1.02
Anti-inflammatory activity of salvianolic acid B in microglia contributes to its neuroprotective effect. Neurochem Res (2010) 1.02
Wafer-level photocatalytic water splitting on GaN nanowire arrays grown by molecular beam epitaxy. Nano Lett (2011) 1.02
Lipocalin 2 is a selective modulator of peroxisome proliferator-activated receptor-gamma activation and function in lipid homeostasis and energy expenditure. FASEB J (2010) 1.01
A functional variation in pre-microRNA-196a is associated with susceptibility of esophageal squamous cell carcinoma risk in Chinese Han. Biomarkers (2010) 1.00
PKD1 inhibits cancer cells migration and invasion via Wnt signaling pathway in vitro. Cell Biochem Funct (2007) 0.99
Cyclin-dependent kinase phosphorylation of RUNX1/AML1 on 3 sites increases transactivation potency and stimulates cell proliferation. Blood (2007) 0.99
Filipino version of the M. D. Anderson Symptom Inventory: validation and multisymptom measurement in cancer patients. J Pain Symptom Manage (2006) 0.98
Clinical value of Helicobacter pylori stool antigen test, ImmunoCard STAT HpSA, for detecting H pylori infection. World J Gastroenterol (2004) 0.98
Defects in SUMO (small ubiquitin-related modifier) conjugation and deconjugation alter cell sensitivity to DNA topoisomerase I-induced DNA damage. J Biol Chem (2005) 0.97
Protein concerted motions in the DNA-human topoisomerase I complex. Nucleic Acids Res (2003) 0.97
Russian Brief Pain Inventory: validation and application in cancer pain. J Pain Symptom Manage (2007) 0.97
Detection of single-electron charging in an individual InAs quantum dot by noncontact atomic-force microscopy. Phys Rev Lett (2005) 0.97
Nonlinear spin current and magnetoresistance of molecular tunnel junctions. Phys Rev Lett (2006) 0.96
Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons. FASEB J (2006) 0.95
MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis. Carcinogenesis (2012) 0.95
Mutation of Gly721 alters DNA topoisomerase I active site architecture and sensitivity to camptothecin. J Biol Chem (2007) 0.94
Effect on DNA relaxation of the single Thr718Ala mutation in human topoisomerase I: a functional and molecular dynamics study. Nucleic Acids Res (2005) 0.94
NMR structure of a heterodimeric SAM:SAM complex: characterization and manipulation of EphA2 binding reveal new cellular functions of SHIP2. Structure (2012) 0.93
Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies. Neurobiol Dis (2005) 0.93
The deubiquitinating enzyme Doa4p protects cells from DNA topoisomerase I poisons. J Biol Chem (2004) 0.93
Brief cognitive-behavioral audiotape interventions for cancer-related pain: Immediate but not long-term effectiveness. Cancer (2006) 0.92
Alterations in linker flexibility suppress DNA topoisomerase I mutant-induced cell lethality. J Biol Chem (2007) 0.92
A single mutation in the 729 residue modulates human DNA topoisomerase IB DNA binding and drug resistance. Nucleic Acids Res (2008) 0.92
Active site mutations in DNA topoisomerase I distinguish the cytotoxic activities of camptothecin and the indolocarbazole, rebeccamycin. J Biol Chem (2001) 0.92
Single nucleotide polymorphisms in the ectomycorrhizal mushroom Tricholoma matsutake. Microbiology (2007) 0.92
Thr729 in human topoisomerase I modulates anti-cancer drug resistance by altering protein domain communications as suggested by molecular dynamics simulations. Nucleic Acids Res (2008) 0.91
Expression, purification of herpes simplex virus type 1 UL4 protein, and production and characterization of UL4 polyclonal antibody. J Virol Methods (2009) 0.91
Graphene spintronics: the role of ferromagnetic electrodes. Nano Lett (2010) 0.90
End-of-life care in urban areas of China: a survey of 60 oncology clinicians. J Pain Symptom Manage (2004) 0.90
Efficacy of low-release-rate fluocinolone acetonide intravitreal implants to treat experimental uveitis. Arch Ophthalmol (2006) 0.90
Distinct functional domains of Ubc9 dictate cell survival and resistance to genotoxic stress. Mol Cell Biol (2006) 0.90
Conductance of an ensemble of molecular wires: a statistical analysis. Phys Rev Lett (2005) 0.90
Validation study of the Chinese version of the Brief Fatigue Inventory (BFI-C). J Pain Symptom Manage (2004) 0.90
Trapping of DNA topoisomerase I on nick-containing DNA in cell free extracts of Saccharomyces cerevisiae. DNA Repair (Amst) (2006) 0.90
Catalytic mechanism of cellulose degradation by a cellobiohydrolase, CelS. PLoS One (2010) 0.89
Platinated DNA adducts enhance poisoning of DNA topoisomerase I by camptothecin. J Biol Chem (2004) 0.89
Induction of immune responses in mice by vaccination with Liposome-entrapped DNA complexes encoding Toxoplasma gondii SAG1 and ROP1 genes. Chin Med J (Engl) (2003) 0.89
4-Hydroxytamoxifen induces autophagic death through K-Ras degradation. Cancer Res (2013) 0.89
Baicalin regulates neuronal fate decision in neural stem/progenitor cells and stimulates hippocampal neurogenesis in adult rats. CNS Neurosci Ther (2013) 0.89
The different cleavage DNA sequence specificity explains the camptothecin resistance of the human topoisomerase I Glu418Lys mutant. Nucleic Acids Res (2006) 0.88
Mutation of a conserved active site residue converts tyrosyl-DNA phosphodiesterase I into a DNA topoisomerase I-dependent poison. J Mol Biol (2007) 0.88
Substitution of conserved residues within the active site alters the cleavage religation equilibrium of DNA topoisomerase I. J Biol Chem (2004) 0.88
Characterization of the subcellular localization of herpes simplex virus type 1 proteins in living cells. Med Microbiol Immunol (2010) 0.87
A dominant CD4(+) T-cell response to Helicobacter pylori reduces risk for gastric disease in humans. Gastroenterology (2012) 0.87
Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy. Pediatr Nephrol (2010) 0.86
Thermal properties of carbon nanotube-copper composites for thermal management applications. Nanoscale Res Lett (2010) 0.86
An association study of single nucleotide polymorphisms of the FOXP3 intron-1 and the risk of Psoriasis vulgaris. Indian J Biochem Biophys (2012) 0.85
A general acid-base mechanism for the stabilization of a tetrahedral adduct in a serine-carboxyl peptidase: a computational study. J Am Chem Soc (2005) 0.85
Functional CT for assessment of early vascular physiology in liver tumors. Hepatobiliary Pancreat Dis Int (2008) 0.85
Assessment of cancer pain management knowledge in southwest China: a survey of 259 physicians from small city and county hospitals. J Palliat Med (2013) 0.85
Genetic diversity of Plasmodium vivax population in Anhui province of China. Malar J (2014) 0.85